<DOC>
	<DOC>NCT01611870</DOC>
	<brief_summary>The purpose of this study is to evaluate the performance of AVAPS AE therapy in COPD patients during nocturnal ventilation.</brief_summary>
	<brief_title>AVAPS-AE Algorithm in Chronic Obstructive Pulmonary Disease (COPD)Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<criteria>Age greater than or equal to 18 years Diagnosis of COPD Currently using a Bilevel device Documentation of medical stability by PI Subjects, who are acutely ill, medically complicated or who are medically unstable Subjects in whom PAP therapy is otherwise medically contraindicated Subjects who have had surgery of the upper airway, nose, sinus, or middle ear within the previous 90 days Subjects with untreated, nonOSA sleep disorders, including but not limited to; insomnia, periodic limb movement syndrome, or restless leg syndrome (PLMI &gt; 10)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>COPD</keyword>
</DOC>